Interestingly, even though CSF1R-inhibition fails to deplete TAMs in this condition, profound phenotypic changes occur whereby the TAMs demonstrate an M1 expression signature and contribute to increased survival in murine PDGF-driven glioma models [132]. The gene discussed is CSF1R; the disease is central nervous system cancer.